Literature DB >> 30987569

Immunopathogenesis of Behçet Disease.

Israel Gañán Nieto1, José Luis Castañer Alabau1.   

Abstract

BACKGROUND: Behçet's Disease (BD, OMIM 109650) is a chronic relapsing inflammatory disease of unknown etiology with unpredictable exacerbations and remissions. First described in 1937 by the Turkish dermatologist HulusiBehçet, as a trisympton complex (oral and genital ulcers and uveitis), it is now recognized as a multisystemic disease. The syndrome can manifest in diverse ways and can involve nearly every organ system. Several studies have implicated T cells and monocytes in the pathogenesis of BD especially when these cells are stimulated by heat shock proteins and streptococcal antigen. This article presents a review of the relevant published literature about the immunopathogenesis of BD. RESULT: The authors used MeSH terms "Behçet's disease" with "pathophysiology," "pathogenesis," "genetic", "epigenetic", "immunogenetic" or "immune response" to search the PubMed database. All the relevant studies identified were included. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Behçet's disease; epigenetics; etiology; genetics; immunopathogenesis; pathophysiology.

Mesh:

Year:  2020        PMID: 30987569     DOI: 10.2174/1573397115666190415142426

Source DB:  PubMed          Journal:  Curr Rheumatol Rev        ISSN: 1573-3971


  2 in total

1.  Effect of different cytokines in combination with IL-15 on the expression of activating receptors in NK cells of patients with Behçet's disease.

Authors:  Nilgun Sallakci; Ilhan Tahrali; Umut Can Kucuksezer; Esin Aktas Cetin; Ahmet Gul; Gunnur Deniz
Journal:  Immunol Res       Date:  2022-06-03       Impact factor: 4.505

2.  Curcumin and Curcuma longa Extract in the Treatment of 10 Types of Autoimmune Diseases: A Systematic Review and Meta-Analysis of 31 Randomized Controlled Trials.

Authors:  Liuting Zeng; Tiejun Yang; Kailin Yang; Ganpeng Yu; Jun Li; Wang Xiang; Hua Chen
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.